CHEMCATCHEM
FULL PAPERS
In situ preparation of [Rh{k1-P-Ph2P(CH2)3OEt}2(NC5H10)(HNC5H10)]
(9): [Rh{k2-PO-Ph2P(CH2)3OEt}2][PF6] (5) (0.020 mmol) reacted with
piperidine (0.060 mmol) in [D8]THF (0.5 mL, in an NMR tube). The
solution that contained a mixture of 7 and 8 was heated at 343 K
for 2 h. 1H NMR evidenced the formation of 9 and [H2NC5H10]+.
Data for 9: 1H NMR (298 K, [D8]THF): d=7.53–7.35 (m, 20H, Ph),
functionalised phosphine ligands allows for a p–p intramolecu-
lar interaction between two phenyl groups. This interaction
provides a rigid scaffold that directs both hemilabile arms to-
wards the same side of the molecular plane, facilitating the
protection of the accessible coordination sites at the rhodium
centre. As a consequence, the observed hemilabile effect could
be related with the stabilization of polar species in solution or
unsaturated catalytic intermediates by transient O-
coordination.
3.87 (brs, 1H, CH2 amido), 3.59 (brs, 2H, CH2O), 3.42 (q, 2H, JHÀH
=
7.2 Hz, CH2CH3), 3.36 (q, 2H, JHÀH =7.0 Hz, CH2CH3), 3.25 (brs, 2H,
CH2O), 3.09 (brs, 1H, CH2 amido), 3.01 (brs, 1H, CH2 amido), 2.85
(s, CH2), 2.44, 2.43, 2.28, 1.98, 1.97 (brs, 1H each, CH2 amido), 1.81
(brs, 2H, CH2P), 1.78 (brs, 2H, CH2), 1.57 (s, CH2), 1.55 (brs, 1H, CH2
amido), 1.40 (brs, 1H, CH2 amido), 1.34 (brs, 2H, CH2P), 1.27 (brs,
2H, CH2), 1.12 (t, 3H, JHÀH =7.0 Hz, CH2CH3), 1.10 ppm (t, 3H, JHÀH
7.5 Hz, CH2CH3). 31P{1H} NMR (298 K, [D8]THF): d=39.60 (dd, JPÀRh
165.0 Hz, JPÀP =51.3 Hz), 36.31 ppm (dd, JPÀRh =173.1 Hz, JPÀP
=
=
=
Experimental Section
General
51.3 Hz). 13C{1H} NMR (298 K, [D8]THF): d=131.28–127.89 (m, Ph),
70.52 (d, JCÀP =13.4 Hz, CH2O), 70.38 (d, JCÀP =13.6 Hz, CH2O), 69.94
(d, CH2CH3), 65.61 (CH2CH3), 53.28, 49.40 (CH2 amido), 29.53 (d,
Reactions were performed under exclusion of air by using standard
Schlenk techniques. Solvents were dried by known procedures and
distilled under argon just prior to use, or obtained from a solvent
purification system (Innovative Technologies). CDCl3, CD2Cl2,
[D8]THF (Euriso-top) were dried using activated molecular sieves.
The functionalised hemilabile phosphine, Ph2P(CH2)3OEt,[17] and cat-
alyst precursors 1–6[15] were prepared following published meth-
ods (see the Supporting Information).
J
CÀP =25.9 Hz, CH2P), 29.40 (CH2 amido), 27.42 (d, JCÀP =20.9 Hz,
CH2P), 26.11 (CH2), 25.92 (CH2 amido), 24.49 (CH2), 23.86 (CH2
amido), 22.22 (d, JCÀP =14.5 Hz, CH2), 22.20 (d, JCÀP =17.3 Hz, CH2),
1
14.65 (CH2CH3), 14.59 ppm (CH2CH3). Data for [H2NC5H10]+: H NMR
(298 K, [D8]THF): 4.38 (br, 2H, NH2+), 2.85 (s, CH2), 1.57 ppm (s,
CH2). 13C{1H} NMR (298 K, [D8]THF): d=46.61, 26.11, 24.49 ppm
(CH2).
Reaction of [Rh{k2-P,O-Ph2P(CH2)3OEt}2][PF6] (5) with
piperidine
Reaction of [Rh(cod){k2-P,O-Ph2P(CH2)3OEt}][BF4] (1) with
piperidine
Formation
of
[Rh{k1-P-Ph2P(CH2)3OEt}{k2-P,O-Ph2P(CH2)3OEt}-
Piperidine (2 mL, 0.02 mmol) was added at RT to a solution of
1 (11.40 mg, 0.02 mmol) in [D8]THF (0.5 mL, NMR tube). Spectro-
scopic NMR analysis showed the formation of an equimolar mix-
ture of [Rh(cod){k1-P-Ph2P(CH2)3OEt}2][BF4] (3) and [Rh(cod)-
(HNC5H10)][PF6] (7): To a solution of [Rh{k2-P,O-Ph2P(CH2)3OEt}2][PF6]
(5, 16.0 mg, 0.02 mmol) in [D8]THF (0.5 mL, in an NMR tube) at RT,
piperidine (2.00 mL, 0.02 mmol) was added to give an orange solu-
1
1
tion of 7. H NMR (253 K, [D8]THF): d=8.35–6.59 (m, 20H, Ph), 4.42,
(HNC5H10)2][BF4] (10). Data for 10: H NMR (298 K, [D8]THF): d=4.03
4.07 (brs, 2H, CH2O), 3.46 (q, 4H, JHÀH =6.9 Hz, CH2CH3), 3.43 (q,
4H, JHÀH =6.8 Hz, CH2CH3), 3.31 (brs, 1H, CH2O), 3.31–1.99 (m, 8H,
4H CH2 pip+4H CH2), 1.76–1.17 (m, 4H, CH2 pip, 4H CH2), 1.19 (t,
6H, JHÀH =7.2 Hz, CH2CH3), 1.14 (t, 6H, JHÀH =6.9 Hz, CH2CH3), 0.74
(brs, 1H, CH2 pip), 0.38 ppm (br, 1H, CH2 pip). 31P{1H} NMR (253 K,
[D8]THF): d=50.24 (dd, JPÀRh =215.0 Hz, JPÀP =54.4 Hz), 30.23 ppm
(dd, JPÀRh =161.0 Hz, JPÀP =54.5 Hz). 13C{1H} NMR (253 K, [D8]THF):
d=137.34 (d, JCÀP =47.0 Hz, Cipso), 135.33 (d, JCÀP =46.9 Hz, Cipso),
132.23–128.28 (Co, Cp, Cm), 70.72 (CH2CH3), 69.83 (CH2O), 68.61
(CH2O), 65.94 (CH2CH3), 48.87, 48.56 (CH2 pip), 29.15 (CH2), 27.61
(CH2 pip), 26.90 (CH2), 24.04, 24.19 (CH2 pip), 22.26, 20.28 (CH2),
14.90, 12.69 ppm (CH2CH3). MS/ESI+ (MeOH, m/z): 731 ([M]+).
(br, 4H, =CH cod), 2.80 (brs, 4H, CH2 pip), 2.41–2.33 (m, 8H, CH2
cod), 1.79–1.56 ppm (br m, 6H, CH2 pip). 13C{1H} NMR (298 K,
[D8]THF): d=81.19 (br d, JCÀRh =13.2 Hz, =CH cod), 48.99, 29.86
(CH2 pip), 27.86 (CH2 cod), 25.84 ppm (CH2 pip).
Reaction of [Rh(cod){k1-P-Ph2P(CH2)3OEt}2][BF4] (3) with
piperidine
In situ preparation of [Rh(cod){NC5H10}{Ph2P(CH2)3OEt}2][BF4] (11): Pi-
peridine (70 mL, 0.712 mmol) was added to a solution of 3 (15 mg,
0.018 mmol) in [D8]THF (0.5 mL, NMR tube). The solution was
heated at 333 K for 20 min., or alternatively left at 298 K for
24 h.1H NMR (298 K, [D8]THF): d=7.33–7.05 (m, 20H, Ph), 4.93 (br,
4H, =CH cod), 3.18 (q, 4H, JHÀH =7.0 Hz, CH2CH3), 3.08 (t, 4H,
Reaction of 5 with piperidine in excess; formation of [Rh{k1-P-Ph2P-
(CH2)3OEt}2(HNC5H10)2][PF6] (8): To a solution of [Rh{k2-PO-Ph2P-
(CH2)3OEt}2][PF6] (5), 16.0 mg, 0.02 mmol) in [D8]THF (0.5 mL, in
NMR tube) at RT, an excess of piperidine (8.00 mL, 0.08 mmol) was
added. The colour of the solution immediately changed to orange
J
HÀH =6.3 Hz, CH2O), 2.85 (brs, 2H, CH2), 2.77 (m, 4H, CH2 cod), 1.89
(brs, 4H, CH2 cod), 1.57 (brs, 2H, CH2), 0.97 ppm (t, 6H, JHÀH
7.0 Hz, CH2CH3). 31P{1H} NMR (298 K, [D8]THF): d=30.62 ppm (d,
PÀRh =199.5 Hz). 13C{1H} NMR (298 K, [D8]THF): d=130.52 (t, J=
=
1
because of the formation of 8. H NMR (193 K, [D8]THF): d=7.89–
J
7.16 (m, 20H, Ph), 3.37 (q, 4H, JHÀH =6.9 Hz, CH2CH3), 3.34 (brs, 4H,
CH2O), 3.14 (m, 2H, CH2 pip), 2.91 (t, 2H, JHÀH =11.0 Hz, CH2 pip),
2.84 (m, 2H, CH2 pip), 2.49 (t, 2H, JHÀH =11.0 Hz, CH2 pip), 2.04 (m,
2H, CH2 pip), 1.92 (brs, 4H, CH2), 1.69 (brs, 2H, CH2 pip), 1.50–1.32
5.8 Hz, Co), 125.91 (Cp), 125.30 (t, J=4.2 Hz, Cm), Cipso (not observed),
100.20 (m, =CH cod), 69.32 (t, J=7.6 Hz, CH2O), 63.72 (CH2CH3),
48.01 (CH2 pip), 30.94 (CH2 cod), 28.00 (CH2), 27.71 (CH2 pip), 24.22
(CH2 pip), 26.81 (t, J=13.0 Hz, CH2P), 12.85 ppm (CH2CH3).
(m, 8H, 4H CH2 pip+2H CH2 pip+4H CH2), 1.16 (6H, t, JHÀH
=
7.0 Hz, CH2CH3), 0.42 ppm (CH2 pip). 31P{1H} NMR (193 K, [D8]THF):
d=38.29 ppm (d, JPÀRh =170.2 Hz). 13C{1H} NMR (193 K, [D8]THF):
d=136.52 (d, JCÀP =44.3 Hz, Cipso), 132.69–129.00 (m, Ph), 70.62
(CH2O), 66.04 (CH2CH3), 50.26 (CH2 pip), 46.71 (CH2 pip), 27.95 (CH2
pip), 27.49 (CH2P), 26.30 (CH2 pip), 25.01 (CH2 pip), 23.76 (CH2),
15.13 ppm (CH2CH3).
Synthesis of [Rh{k1-P-Ph2P(CH2)3OEt}2(N2C5H12)][PF6] (13)
N-methylpiperazine (8.40 mL, 0.088 mmol) was added to a solution
of [Rh{k2-PO-Ph2P(CH2)3OEt}2][PF6] (5) (60.0 mg, 0.088 mmol) in THF
(4 mL) at RT and the solution stirred for 1 h. The volatiles were re-
ꢁ 2013 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
ChemCatChem 2013, 5, 263 – 276 274